CURRENT
DOE-SPEC-1142-2019, Beryllium Lymphocyte Proliferation Testing (BeLPT)
This specification is for beryllium lymphocyte proliferation tests (BeLPT) used for detecting whether an individual has developed a sensitization to beryllium and for clinical evaluation and diagnosis of patients for chronic beryllium disease (CBD). However, a lung biopsy is needed to fully establish the presence of CBD. This specification should be used in all contracts with laboratories for the purchase of BeLPT Services. Supersedes DOE-SPEC-1142-2001, dated 5-7-2001.
DOE-SPEC-1142-2019.pdf -- PDF Document, 382 KB
| Subjects: |
|
| ID: | DOE-SPEC-1142-2019 |
| Type: | Specification |
| Senior Line Manager: | Dressman, Kevin |
| Senior Line Manager Org: | EH-10 |
| OPI: | EHSS - Office of Environment, Health, Safety and Security |
| Preparing Activity: | Isaf Al-Nabulsi |
| Status: | Current |
| Approved Date: | Dec 16, 2019 |
| Last Update: | Dec 16, 2019 |
| DNFSB Interest: | |
| Invoked Standard: | No |
There are no Directives invoking this standard.
There are no Directives referencing this standard.
